Hepatic stellate cells: A target for the treatment of liver fibrosis

Journal of Gastroenterology

Volumn 35, Issue 9, 2000, Pages 665-672

  Wu, J ^a   Zern, M A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chinese herbal medicine; Cirrhosis; Fibrosis; Hepatic stellate cells; Liver; Platelet derived growth factor; Reactive oxygen species; S adenosyl L methionine; Transforming growth factor ; Treatment; Tumor necrosis factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIOXIDANT; ARGINYLGLYCYLASPARTIC ACID; CH 100; CHINESE HERB; CYTOKINE; GLYCYRRHIZIC ACID; HAN DAN GAN LE; PENTOXIFYLLINE; PHOSPHATIDYLCHOLINE; PLANT EXTRACT; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; POLYENE PHOSPHATIDYLCHOLINE; REACTIVE OXYGEN METABOLITE; RECEPTOR BLOCKING AGENT; RECIPE 861; S ADENOSYLMETHIONINE; SILYMARIN; SU 5874; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG; XIAO CHAI HU TANG;

CELL ACTIVATION; DRUG TARGETING; EXTRACELLULAR MATRIX; FIBROGENESIS; HUMAN; KUPFFER CELL; LIVER CELL; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STELLATE CELL; WOUND HEALING;

ANTIOXIDANTS; CYTOKINES; DRUGS, CHINESE HERBAL; EXTRACELLULAR MATRIX; GROWTH SUBSTANCES; HEPATOCYTES; HUMAN; LIVER CIRRHOSIS; SILYMARIN; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR;

EID: 0033781716     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350070045     Document Type: Review

References (79)

1. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies
2. Cytokines and cellular crosstalk involved in the activation of fat-storing cells
3. Prevention and treatment of liver fibrosis based on pathogenesis
4. Human liver growth in fibrosis and cirrhosis
5. Cell-matrix interactions in liver
6. Transformation of fat-storing cells into transitional cells in alcoholic liver fibrosis
7. Inhibition of hepatic fibrogenesis, a review of pharmacological candidates
8. Toxicity of hepatotoxins: New insights into mechanisms and therapy
9. Detection of hepatic fibrogenesis, a review of available techniques
10. Animal models of liver fibrosis
11. Molecular mechanisms in the reversible regulation of morphology, proliferation and collagen metabolism in hepatic stellate cells by the three-dimensional structure of the extracellular matrix
12. Role of metalloproteinases in liver fibrosis
13. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: Role of stellate cells
14. Tissue inhibitors of metalloproteinases: Role in liver fibrosis and alcoholic liver fibrosis
15. Cytokine regulation of hepatic stellate cells in liver fibrosis
16. Inhibition of carbon tetrachloride-induced liver injury by liposomes containing vitamin E
17. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents
18. Long- And short-term D-α-tocopherol supplement inhibits liver collagen α1(I) gene expression
19. A pilot study of the effects of d-α-tocopherol on hepatic stellate cell activation in chronic hepatitis C
20. Leukocytes as modulators of stellate cell activation
21. Gene expression of transforming growth factor-β1 and extracellular matrix proteins in murine Schistosoma mansoni infection
22. Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis
23. TGF-β isoforms in alcoholic liver disease
24. Hepatic expression of mature transforming growth factor-β1 in transgenic mice results in multiple tissue lesions
25. TGF-β1 in liver fibrosis: An inducible transgenic mouse model to study liver fibrogenesis
26. Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells
27. Hepatic stellate (Ito) cells: Expanding roles for a liver specific pericyte
28. Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
29. 4-Hydroxy-2,3-alkenals as molecular mediators of oxidative stress in the pathogenesis of liver fibrosis
30. Acetaldehyde-mediated collagen regulation in hepatic stellate cells
31. Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells
32. Sequential acetaldehyde production, lipid peroxidation and fibrogenesis in micropig model of alcohol-induced liver disease
33. Signal transduction via platelet-derived growth factor receptors
34. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats
35. Effects of silymarin in alcoholic patients with cirrhosis of the liver: Results of controlled, double-blind, randomized and multicenter trial
36. S-Adenosyl-L-methionine synthesis: Molecular mechanisms and clinical implications
37. Protective effect of S-adenosyl-L-methionine on bromobenzene- or D-galactosamine toxicity to isolated rat hepatocytes
38. Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis
39. Effects of S-adenosyl-L-methionine and interferon-α on liver damage induced by bile duct ligation in rats
40. Biochemical effect of antioxidants on lipids and liver function in experimentally induced liver damage
41. Role of S-adenosyl-L-methionine in the treatment of liver disease
42. S-Adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicenter clinical trial
43. Effect of pentoxifylline on the fibrogenic functions of cultured rat liver fat-storing cells and myofibrolasts
44. Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity
45. Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells
46. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon
47. Lipocytes and transitional cells in alcoholic liver disease: A morphological study
48. Polyenylphosphatidylcholine inhibits PDGF-induced proliferation in rat hepatic stellate cells
49. Dilinoleoylphosphatidylcholine selectively modulates lipopolysaccharide-induced Kupffer cell activation
50. Dilinoleoyl-phosphatidylcholine is the active antioxidant of polyenylphosphatidylcholine
51. 4-exposed rat liver fat-storing cells and facilitates activation of latent transforming growth factor-β in cocultures with sinusoidal endothelial cells
52. E-box-binding repressor is down-regulated in hepatic stellate cells during up-regulation of mannose-6-phosphate/insulin-like growth factor-II receptor expression in early hepatic fibrogenesis
53. Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells
54. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappa-B
55. Tissue transglutaminase (tTG) functions as a G protein and as a cross-linking molecule in ethanol-induced inhibition of hepatocyte proliferation
56. TNF-α modulates expression of the tissue transglutaminase gene in liver cells
57. Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat
58. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis
59. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells
60. Structure of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors
61. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signal events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation
62. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells
63. 4-induced hepatic fibrosis and on hepatic stellate cell proliferation
64. Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat
65. The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture
66. Inhibition of integrin signaling with Arg-Gly-Asp motifs in rat hepatic stellate cells
67. Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on ras in human hepatic stellate cells
68. Inhibition of experimentally induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope
69. Experimental and clinical study on inhibition and reversion of liver fibrosis with integrated Chinese and Western medicine
70. Herbal medicine 861 has direct antiproliferative effects on hepatic stellate cells. NIH sponsored international symposium. Complementary and alternative medicine in chronic liver disease
71. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats
72. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet
73. Strong antiproliferative effects of baicalein in cultured rat hepatic stellate cells
74. Effects of the Japanese herbal medicine ″Sho-saiko-o-to″(TJ-9) on interleukin-12 production in patients with HCV-positive liver cirrhosis
75. 4-plus ethanol-induced liver cirrhosis in rats
76. Therapeutic basis of glycyrrhizin on chronic hepatitis B
77. 4-induceds liver fibrosis in rats
78. Preliminary report of a randomized, double-blind placebo-controlled trial of a Chinese herbal medicine preparation CH-100 in the treatment of chronic hepatitis C
79. α2-Macroglobulin reduces paracrine-and autocrine-stimulated matrix synthesis of cultured rat hepatic stellate cells